•Alcon launches TOTAL30 Multifocal for Astigmatism toric contact lens•Ocular Therapeutix reports positive phase 3 SOL-1 superiority data for wet AMD•Nicox reports positive pre-NDA FDA meeting for IOP-lowering drop•FDA clears Cloudbreak Pharma's IND for phase 2 presbyopia drop trials•FDA approves DifGen's fluorometholone 0.1% complex generic for ocular inflammation•Alcon launches TOTAL30 Multifocal for Astigmatism toric contact lens•Ocular Therapeutix reports positive phase 3 SOL-1 superiority data for wet AMD•Nicox reports positive pre-NDA FDA meeting for IOP-lowering drop•FDA clears Cloudbreak Pharma's IND for phase 2 presbyopia drop trials•FDA approves DifGen's fluorometholone 0.1% complex generic for ocular inflammation
HEADLINES
FEATURED
U.S. age indication now includes patients aged 21 to 60 years old, making nearly 8 million refractive patients eligible for implantable collamer lens implantation.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
